From water purification, to better batteries and tools to foil a cyberattack—a look back at how PNNL helped to invent a brighter and better future over the last year.
A multi-institutional team has obtained information about nanoscale interactions between the spike protein of the novel coronavirus SARS-CoV-2 and common household inorganic surfaces.
A comprehensive literature review linking algae and antivirals determines compounds in algae may demonstrate an exceptional—and as yet untapped—potential to combat viral diseases at every point along the viral infection pathway.
Grid Forward, an industry association dedicated to promoting and accelerating innovation in the regional electric system, honored PNNL's Carl Imhoff with the 2021 Grid Innovator Award.
High-throughput biochemical assays targeting a vital viral protein identified one molecule out of more than 13,000 with promising antiviral activity against SARS-CoV-2.
PNNL has released the first version of ExaGO, an open-source grid modeling software that can take advantage of emerging heterogeneous computing architecture to help grid operators plan ahead for extreme events.
Vigorous and rapid air exchanges might not always be a good thing when it comes to levels of coronavirus particles in a multiroom building, according to a new modeling study.